Multigene panel for common RASopathy genes that includes BRAF, MAP2K1, MAP2K2, KRAS and YWHAZ usually detects up to 90% of individuals with CFC and it is the preferred initial test. This evidence concerns the gene MAP2K2 and RASopathy.